Clinical Study on the Efficacy and Safety of Fluvoxamine tTeatment for the Tumor Related Depressive Status

Authors

  • Hui Peng

  • Jiexia Zhang

  • Xia Wang

  • Yong Liu

  • Yong Liu

  • Jianhui Li

Keywords:

depressive disorder, cancer, fluvoxamine, anxiety, sleep-quality

Abstract

Tumor-related depressive disorder TRDD is a common symptom in the cancer population and is accompanied by an eminent mortality rate Alternative treatment such as psychotropic medication is increasingly used to cope with physical impairments Fluvoxamine one of the widely used medicine its efficacy and safety in cancer patients are unclear

Downloads

How to Cite

Hui Peng, Jiexia Zhang, Xia Wang, Yong Liu, Yong Liu, & Jianhui Li. (2022). Clinical Study on the Efficacy and Safety of Fluvoxamine tTeatment for the Tumor Related Depressive Status. Global Journal of Medical Research, 22(F7), 19–27. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/102204

Clinical Study on the Efficacy and Safety of Fluvoxamine tTeatment for the Tumor Related Depressive Status

Published

2022-07-09